Lykos CEO to depart after FDA rejection, layoffs

cafead

Administrator
Staff member
  • cafead   Sep 05, 2024 at 10:43: PM
via The CEO of Lykos Therapeutics will step down after the company’s efforts to win a milestone approval for MDMA as a therapy aid were rejected by the Food and Drug Administration last month.

article source